Tempus AI is a pioneering company in the field of precision medicine, leveraging advanced technology and artificial intelligence to transform healthcare. Founded in 2015 by Eric Lefkofsky, Tempus aims to provide real-time, actionable insights to physicians by connecting a comprehensive ecosystem of real-world evidence. The company's proprietary platform is designed to enhance drug development and clinical care, ensuring that patients receive the most effective treatments at the right time. With a focus on oncology and expanding into other medical fields such as neuropsychiatry, cardiology, and infectious diseases, Tempus collaborates with over 200 biopharmaceutical organizations, including 18 of the top 20, to accelerate research and innovation in the healthcare industry. The company is committed to building a diverse and inclusive workforce, seeking individuals who are passionate about making a difference in the world of medicine.